Skip to main content
Equibles

Walleye Capital LLC

Position in ACB — Aurora Cannabis Inc

CIK 1758720 NEW YORK, NY
Back to ACB Full portfolio

Position in ACB

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$2
-$30,841 QoQ
Shares Held
1
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#145
of 149 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACB Over Time

Shares Held

Position Value (USD)

Derivatives in ACB

reported options exposure · as of Jun 30, 2026
CallValue
$140,337
CallShares
50,300
PutValue
$38,223
PutShares
13,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Walleye Capital LLC holds $47,294,180 across 23 Drug Manufacturers - Specialty & Generic names. ACB ranks #23 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 165,410 $11,886,362
2 ANIP
Ani Pharmaceuticals Inc
 106,112 $8,783,951
3 BIOA
BioAge Labs, Inc.
 354,395 $8,686,221
4 XERS
Xeris Biopharma Holdings, Inc.
 611,296 $4,841,464
5 AMLX
Amylyx Pharmaceuticals, Inc.
 186,588 $3,351,120
6 ETON
Eton Pharmaceuticals, Inc.
 86,249 $3,122,213
7 EOLS
Evolus, Inc.
 253,817 $1,761,489
8 AQST
Aquestive Therapeutics, Inc.
 282,568 $1,175,482

All Filings in ACB

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $140,337 50,300
2026-06-30 $2 1
2026-06-30 $38,223 13,700
2025-12-31 $30,843 7,309
2025-12-31 $43,044 10,200
2025-12-31 $186,946 44,300
2025-06-30 $100,488 23,700
2025-06-30 $1,190,168 280,700
2025-06-30 $17,587 4,148